Ceapro Inc. Reports Record 2022 Second Quarter and : vimarsa

– Company boasts highest second quarter sales to date; Q2 2022 sales of $5,500,000 vs $4,409,000 in Q2 2021, a 25% increase – YTD Sales increased 28% vs...

Related Keywords

Montreal , Quebec , Canada , Gilles Gagnon , Bernhard Seifried , Genevieve Foster , Beta Glucan , Montreal Heart Institute , University Of Alberta , Mcmaster University , Company Board Of Directors , Pipeline Development , Corealis Inc , Ceapro Inc , Manufacturing Services , Health Canada , International Symposium On Supercritical Fluids , Processed Alginates , International Symposium , Supercritical Fluids , Corporate Director , Sigrun Watson , Chief Revenue , Second Quarter , Six Month Period Ended June , Interim Consolidated Statements , Net Income , Ended June , Months Ended June , Tsx Venture Exchange Czo ,